Mar 28, 2016 12:30 pm UTC| Business
SALT LAKE CITY, March 28, 2016 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced that clinical data for LPCN 1021, an oral testosterone replacement therapy ("TRT") product candidate...
Mar 28, 2016 12:30 pm UTC| Business
SALT LAKE CITY, March 28, 2016 -- Lipocine Inc. (NASDAQ:LPCN), a specialty pharmaceutical company, today announced that clinical data for LPCN 1021, an oral testosterone replacement therapy ("TRT") product candidate...
RAADR, Inc. iOS App Receives Approval on Apple App Store
Mar 28, 2016 12:30 pm UTC| Business
Phoenix, AZ, March 28, 2016 -- RAADR, Inc. (OTCQB: RDAR), a technology and software development company that monitors cyber bullying and social media platforms through its artificially intelligent proprietary...
OXiGENE Reports 2015 Financial Results
Mar 28, 2016 12:30 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., March 28, 2016 -- OXiGENE, Inc. (Nasdaq:OXGN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of cancer, today reported financial results for...
Mar 28, 2016 12:30 pm UTC| Business
CAMBRIDGE, Mass., March 28, 2016 -- Vericel Corporation (NASDAQ:VCEL), a leading developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, today announced the...
Mar 28, 2016 12:30 pm UTC| Business
NEW YORK and JAKARTA, Indonesia, March 28, 2016 -- PHI Group (OTC Markets:PHIL), a U.S. public company focused on conventional energy and renewables, announced today that it has signed an agreement with PT Perkasa...
Mar 28, 2016 12:30 pm UTC| Business
SAN FRANCISCO, March 28, 2016 -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm reminds PTC Therapeutics (NASDAQ:PTCT) investors of the May 2, 2016 lead plaintiff deadline in the securities fraud...